Alzheimer's risk is increased for those with anosognosia, a condition in which sufferers are unaware they are experiencing memory loss.
Researchers report intermittent theta burst stimulation can help to alleviate the symptoms of major depressive disorder. 49% of patients who received the treatment reported a significant decrease in symptoms, with 32% reporting remission of depression.
According to researchers, 40% of people with treatment resistant depression who received rTMS no longer had suicidal thoughts following treatment.
A new study reveals people with schizophrenia have a disrupted stress response. Researchers report those with schizophrenia have an increase in dopamine release in the striatum, but not in the prefrontal cortex, in response to stress.
Amiloride, a common blood pressure medication, shows potential in treating anxiety disorder and pain when administered in nebulized form, researchers report.
A new study reports sub-groups of people use their brains differently when imitating emotional faces. For those with schizophrenia, researchers found no categorically different social brain functions than those without the condition, but do fall into different sub-groups that respond to different types of treatments.
Researchers have developed new therapeutic molecules that appear to assist in reversing memory loss associated with depression and aging.
Study demonstrates a molecular mechanism that contributes to the development of PTSD. The findings could lead to therapeutic interventions for preventing or treating the disorder.